Baillie Gifford - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 68 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2018$70,569,000
-47.3%
882,105
-34.5%
0.08%
-47.2%
Q2 2018$133,826,000
+23.5%
1,347,282
+0.7%
0.14%
+13.4%
Q1 2018$108,403,000
+2.1%
1,338,314
-0.7%
0.13%
-3.8%
Q4 2017$106,166,000
-13.8%
1,347,795
+1.0%
0.13%
-15.4%
Q3 2017$123,165,0001,334,8200.16%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q4 2018.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders